Molecular and Cellular Therapeutics

From discovery to medicine

A unit of the Office of Academic Clinical Affairs, Molecular and Cellular Therapeutics offers state-of-the-art GMP/GTP compliant, full-service development and manufacturing of cell- and tissue-based products, monoclonal antibodies and other therapeutic proteins, as well as active pharmaceutical ingredients, for use in Phase I or II clinical trials. 

Our fully-staffed technical and quality personnel with product development, medical, and regulatory expertise, work to compress development timelines and translate research into medicine.

MCT Workmark side